CD4 and diabetes mellitus: In contrast, approximately 80% of the NOD-HET remained diabetes free, and this was accompanied by reduced iPLA2β (~65%) (Figure 3C) and TNF-α production by CD4+ T cells (Figure 3D) and higher M2 marker, Arg1 (Figure 3E), relative to NOD.